Farkas K Christopher 4
4 · CURTISS WRIGHT CORP · Filed Mar 18, 2026
Research Summary
AI-generated summary of this filing
Curtiss‑Wright CFO Christopher Farkas Sells 918 Shares
What Happened
Christopher K. Farkas, Executive Vice President and Chief Financial Officer of Curtiss‑Wright Corp (CW), had 2,183 restricted stock units (RSUs) vest and convert into common shares on March 16, 2026 (acquired at $0.00). Following the vesting, he sold 918 shares in an open‑market transaction on March 17, 2026, for total proceeds of approximately $621,908 (average price reported $677.46; sale prices ranged $669.72–$681.43). The remaining shares from the vesting were retained or used to satisfy withholding as noted in the filing.
Key Details
- Transaction dates: RSU conversion/derivative event on 2026-03-16; open‑market sale on 2026-03-17. Filing date: 2026-03-18 (timely).
- Shares acquired via vesting/conversion: 2,183 shares at $0.00 (RSU cliff vested from grant on 2023-03-16).
- Shares sold: 918 shares; average selling price $677.46; total proceeds ≈ $621,908. Sales occurred in multiple transactions at $669.72–$681.43.
- Purpose/footnotes: Sale executed in compliance with company share‑ownership guidelines to cover tax obligations on the vesting award; reporting person remains in compliance. Share totals include dividend credits on prior grants.
- Shares owned after the transactions: Not specified in the filing.
Context
This was a vesting of previously granted RSUs (a non‑cash award) that converted into common stock; a portion was sold soon after vesting to cover taxes — a routine, administrative sale rather than an open‑market purchase signaling additional insider accumulation. The filing shows a derivative exercise/conversion code (M) for the RSU vesting and a sale code (S) for the open‑market disposition.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1][F2]2026-03-16+2,183→ 6,436 total - Sale
Common Stock
[F3][F4]2026-03-17$677.46/sh−918$621,908→ 5,518 total - Exercise/Conversion
Restricted Stock Unit
[F2][F1][F5]2026-03-16−2,183→ 9,366 totalExercise: $0.00From: 2026-03-16Exp: 2026-03-16→ Common Stock (2,183 underlying)
Footnotes (5)
- [F1]These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
- [F2]No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
- [F3]Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
- [F4]The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $669.72 to $681.43, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
- [F5]Share total includes dividend credits earned on prior outstanding grants.